Life Sciences’ Digital Leap: This Year's Indegene Summit
Theme for this year's virtual event is delivering digital impact at scale.
This year's Indegene Digital Summit takes off as a multi-week, virtual event on September 25, with the next sessions on October 2 and October 16.
Scott Gottlieb, MD, former commissioner of the Food & Drug Administration, will deliver the keynote address. He will be joined by other keynote speakers including Sebastian Guth, PhD (President, Americas Region, Bayer Pharmaceuticals), Daniel Kraft, MD (Chair for Medicine, Singularity University and Founder and Chair, Exponential Medicine), Richard Ashworth, (President, CEO, and Board Member, Tivity Health; Former President, Walgreens), and Aseem Puri, (Chief Marketing Officer, Unilever International). The theme for this year’s summit is Life Sciences’ Digital Leap from x to 10x – delivering digital impact @ scale.
“The current environment has accelerated the need for a digital reset in the life sciences industry, enabling business leaders to scale up a wide range of digital initiatives. The industry now needs to move away from isolated pockets of excellence and experimentation to a steady, integrated state and scale across the organization,” commented Gaurav Kapoor, EVP, Global Product Commercialization and Co-founder, Indegene,
The event will go live with 60+ speakers and 18+ sessions, with 1500+ attendees joining virtually from across the globe. The participants can also experience unique networking opportunities through mobile app, attendee roundtables, and networking lounge.
Click here for a 1-min preview video. To learn more and register for the Summit, click here.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
